NCT03156361View on ClinicalTrials.gov

21 Day Comparison of Continuous Insulin Infusion Using HDV Insulin to Standard Insulin in Type 1 Diabetes Mellitus

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 18, 2017

Primary Completion Date

January 15, 2018

Study Completion Date

March 15, 2018

Conditions
Type1 Diabetes Mellitus
Interventions
DRUG

HDV insulin lispro 100 UNIT/mL

Hepatic Directed Vesicle (HDV) added to commercial insulin lispro

DRUG

Insulin Lispro 100 Units/mL

Sterile Water for Injection added to commercial insulin lispro

Trial Locations (1)

30318

Atlanta Diabetes Association, Atlanta

Sponsors

Collaborators (1)

Integrium
All Listed Sponsors
collaborator

Integrium

INDUSTRY

lead

Diasome Pharmaceuticals

INDUSTRY

NCT03156361 - 21 Day Comparison of Continuous Insulin Infusion Using HDV Insulin to Standard Insulin in Type 1 Diabetes Mellitus | Biotech Hunter | Biotech Hunter